RE:RE:RE:APHA in Red , while the rest is in a long uptrend Thank you for this detailed post.
Was long with 22000 shares until short attack.
I went cash as many, and traded some with other LPs; only got back to APHA since last week, with the somehow positive news gave me some reassurance.
Not sure if Ill be long or short. need to recuperate some cash I lost :) (I bought into APHA late August@$15.40....
My main concern today is that usually this stock was trading in perfect correlation with WEED, that's not the case anymore.
PosterVi wrote: If you are day trading, this would definitely be a concern but I would advise you to look at the fundementals of the business (they are quite strong). Having said this here is likely what is affecting the stock price:
- GGB hostile take over bid; the market and institutional investors do not like uncertainty and as long as this hangs over Aphria's stock, it will create downwards pressure on the SP.
- Rebuttal; share holders in general are awaiting the rebuttal report to re-affirm what most people know but want to hear the company officially annouce (LATAM assets exist, have value and that no insider self dealing occurred).
- CEO Search: until a new CEO is named, there is a cloud of uncertainty in regards to major business decisions and a long term direction of the company. Under Vic, it was pretty clear that they were going to bio-pharma route with recreational being a secondary play. The fact that the Altria deal went bust under Vic's watch was definitely one of the main catalyst for accelerating his departure. While it is possible that Jakob Riphstein (President) and Irwin Simon (Chair of the Board) may make a decision on a partner for Aphria, it's likely this is part of the negotiations going on right now with whatever parties are interested in taking a stake in Aphria. I should highlight that I do not think GGB is a real partner for Aphria and unless their bid comes in as an all cash deal at a much higher valuation, it's bound to fail.